HIV infection in the era of highly active antiretroviral therapy: The Malaga study

International Journal of STD and AIDS

Volumn 15, Issue 9, 2004, Pages 594-596

  Santos, Jesús ^a   Palacios, Rosario ^a   Gutierrez, Mónica ^b   Grana, Mariela ^c   De La Torre, Javier ^b   Salgado, Fernando ^c   Nuño, Enrique ^d   Márquez, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b HOSPITAL COSTA DEL SOL   (Spain)

^c Hospital de la Serrania   (Spain)

^d Especialidad en Oftalmología Hospital Comarcal de la Axarquía Vélez Málaga Málaga   (Spain)

Author keywords

Epidemiology; HAART; HIV infection; Late diagnosis; New diagnosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX; SEXUALLY TRANSMITTED DISEASE; SPAIN; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; SPAIN; VIRAL LOAD;

EID: 4644299586     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462041724253     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Guidelines for National Human Immunodeficency Virus Case Surveillance, Including Monitoring for Human Immunodeficency Virus Infection and Acquired Immunodeficency Syndrome. MMWR 1999;48(RR13):1-28
2. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999;13:1933-42
3. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with know HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA 1998;280:1497-503
4. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60
5. CDC. Update: trends in AIDS incidence, United States, 1996. MMWR 1997;46:861-7
6. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS surveillance in Europe. Report no. 61, 30 de junio de 1999
7. Moreno C, Huerta I, Lezaún ME, González A. Grupo Espanol Multicéntrico para el Estudio de Seroconvertores. El periodo de incubación del sida en España antes de la terapia antirretroviral de alla eficacia. Med Clin (Barc) 2000;115:681-6
8. Castilla J, Sobrino P, de la Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002;16:1945-51
9. Hamers FF, Infuso A, Alix J, Downs AM. Current situation and regional perspective of HIV/AIDS surveillance in Europe. J Acquir Immune Defic Syndr 2003;32(Suppl 1):S39-48
10. Moreno C, Huerta I, Lezaún ME, González A, Sola J, Castilla J. Evolución del número de nuevos diagnósticos de infección por VIH en Asturias, Navarra y la Rioja. Med Clin (Barc) 2000;114:653-5
11. López de Munain J, Cámara MM, Santamaría JM, Zubero Z, Baraia-Etxaburu J, Muñoz J. Características clinicoepidemiológicas de los nuevos diagnósticos de infección por el virus de la inmunodeficiencia humana. Med Clin (Barc) 2001;117:654-6
12. Castilla V, Alberdi JC, Barros C, Gómez J, Caspar G, Sanz J. Cohorte multicéntrica de pacientes con infección VIH de la corona metropolitana sur-este de Madrid (COMESEM): fundamentos, organización y resultados iniciales. Rev Clin Esp 2003;203:170-7
13. Suárez-Lozano I, Fajardo JM, Garrido M, Roca B, García-Alcalde ML, Geijo P, et al. Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort). AIDS 2002;16:2496-9
14. Klein D, Hurley LB, Merrill D, Quesenberry CP. Review of Medical Encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr 2003;32:143-52